# Ars Pharmaceuticals (SPRY): value investors who own it

1 value investor held Ars Pharmaceuticals in their Q2 2026 13F, led by Third Point. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Third Point | 0.2% | $8.0m | Unchanged | 3 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/spry). Values traded and returns are estimates. Not investment advice. Built 2026-10-23.